• Thu news: Industry M&A volume down 8% over 2023. Pfizer’s Ibrance improves breast cancer survival. Lonza shedding capsule biz. AZ’s Lynparza in early breast cancer. Trump wants childhood vaccine discussion. See more on our front page

AAOS







we are all too busy walking the aisles looking for other lines to carry, waiting for commission deductions and waiting to see who has the cahoonas to walk up to Dr Petty and take his blinders off. Corporate people here wasting corporate dollars getting drunk and pretending to know how to run a real orthopedic company. Put us out of our misery and get bought already.
 






we are all too busy walking the aisles looking for other lines to carry, waiting for commission deductions and waiting to see who has the cahoonas to walk up to Dr Petty and take his blinders off. Corporate people here wasting corporate dollars getting drunk and pretending to know how to run a real orthopedic company. Put us out of our misery and get bought already.

no one is going to buy a company for bone spacers and also have to pay the royalties to surgeons and reps. that's the part everyone seems to be missing. What a joke. Buy us.....for what the fourth best shoulder on the market. what a joke